Targeting CK2-mediated phosphorylation of p53R2 sensitizes BRCA-proficient cancer cells to PARP inhibitors

Oncogene, Published online: 24 August 2023; doi:10.1038/s41388-023-02812-5Targeting CK2-mediated phosphorylation of p53R2 sensitizes BRCA-proficient cancer cells to PARP inhibitors

Source: Oncogene - August 24, 2023 Category: Cancer & Oncology Authors: Cong Wang Ling Tian Qiang He Shengbin Lin Yue Wu Yiting Qiao Bo Zhu Dake Li Guo Chen Source Type: research